Key facts
- FHIREngine’s last known valuation is $2.1M (Mar 2025).
- It has raised $790K across 1 recorded rounds; the latest was Seed Round ($793K) in Mar 2025.
- FHIREngine has filed 1 Form D with the SEC, most recently Mar 2025 ($793K sold to 9 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for FHIREngine
Funding rounds
1 roundsAbout FHIREngine
Developer of AI-driven treatment decision support solutions designed to standards and value-based use cases. The company offers utilization management services that digitize payer policies to enable real-time, dynamic point of care interaction between payers, providers, and consumers, their solutions include inpatient level of care, outpatient prior authorization, pharmacy scripts, and ancillary services using AI scoring to recommend the best decision, enabling coding clinical and administrative content into digitized decision treatment questions using their machine learning NLP digitization engine.
- Sector
- Information Technology
- HQ
- Boston, MA, United States
- Founded
- 2021
- Employees
- 10
- Website
- oncosure.ai/
- Ownership
- Privately Held (backing)
FHIREngine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in FHIREngine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on FHIREngine in its N-PORT filings yet. We sweep new filings monthly.